Bendigo, Sep 1, 2022 AEST (ABN Newswire) - Apiam Animal Health Limited (ASX:AHX) MD Dr. Chris Richards speaks with ABN Newswire regarding the Financial Year 2022 results, the accelerated growth strategy and looking ahead to 2023.
Also Dr. Richards talks about the business generally, with continuing acquisitions contributing towards the $300 million annual revenue target for the company.
To view the Video Interview, please visit:
About Apiam Animal Health Limited
Apiam Animal Health Limited (ASX:AHX) is comprised of Australia's leading Production Animal and Mixed Animal veterinary practices. Apiam Animal Health incorporates over 150 highly experienced, industry leading veterinarians with expertise across the pig, dairy, feedlot, sheep, poultry, equine, and companion animal sectors, supported by an experienced administration, nursing, technical services and ancillary team. Apiam Animal Health is fully vertically integrated, including having veterinary wholesale, diagnostics laboratories, custom vaccines, logistics, and other ancillary services.
Apiam Animal Health Limited